Lovenox (enoxaparin) is now approved for unstable angina or after some types of heart attacks

June 1998

The low molecular weight heparin, Lovenox (enoxaparin) is nowapproved for unstable angina or after some types of heart attacks.

It's an alternative to IV heparin...to prevent blood clots andrecurrent heart attacks. These patients are also given aspirin.

Lovenox is more effective than IV heparin for this use...andit's easier to use because it doesn't require monitoring.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote